-
If you purchased shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
September 27, 2013 (Update) - On September 25, 2013, AMAG Pharmaceuticals, Inc. disclosed that on September 23, 2013, the Company received a notification from the U.S. Food and Drug Administration (the FDA) stating that, as part of its ongoing review of the Companys supplemental New Drug Application for its Feraheme Injection, the FDA has identified deficiencies that preclude discussi...
You must register (for free) or login to view the entire investigation.
